FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2

• Main Authors: Ahmed Mostafa (Author), Ahmed Kandeil (Author), Yaseen A. M. M. Elshaier (Author), Omnia Kutkat (Author), Yassmin Moatasim (Author), Adel A. Rashad (Author), Mahmoud Shehata (Author), Mokhtar R. Gomaa (Author), Noura Mahrous (Author), Sara H. Mahmoud (Author), Mohamed GabAllah (Author), Hisham Abbas (Author), Ahmed El Taweel (Author), Ahmed E. Kayed (Author), Mina Nabil Kamel (Author), Mohamed El Sayes (Author), Dina B. Mahmoud (Author), Rabeh El-Shesheny (Author), Ghazi Kayali (Author), Mohamed A. Ali (Author)
• Format: Book
• Published: MDPI AG, 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

(1) Background: Drug repositioning is an unconventional drug discovery approach to explore new therapeutic benefits of existing drugs. Currently, it emerges as a rapid avenue to alleviate the COVID-19 pandemic disease. (2) Methods: Herein, we tested the antiviral activity of anti-microbial and anti-...